Medical treatment of silent myocardial ischemia
1Cardiology, State University of New York, Health Sciences Center at Stony Brook, Stony Brook, New York 11794-8171, USA.
Insights
Silent ischemia, common in coronary artery disease, affects prognosis. While drug therapy can reduce ischemic burden and improve outcomes, coronary revascularization offers greater benefits.
Area of Science:
- Cardiology
- Ischemic Heart Disease
Background:
- Silent myocardial ischemia is highly prevalent in patients with coronary artery disease.
- The underlying pathophysiology of silent ischemia is not fully understood.
- Silent ischemia negatively impacts patient prognosis, regardless of symptoms.
Purpose of the Study:
- To review the detection, prognosis, and therapeutic strategies for silent ischemia in coronary artery disease.
- To highlight the role of Holter monitoring in assessing silent ischemia during daily activities.
Main Methods:
- Review of current literature on silent ischemia detection and management.
- Discussion of stress testing and Holter monitoring as diagnostic tools.
- Evaluation of pharmacologic and revascularization therapies for silent ischemia.
Main Results:
- Holter monitoring is effective for detecting ischemia during daily life and evaluating treatment efficacy.
- Both pharmacologic agents and coronary artery revascularization can reduce ischemic burden.
- Coronary revascularization demonstrates a more significant improvement in prognosis compared to pharmacologic therapy.
Conclusions:
- Silent ischemia is a significant predictor of adverse outcomes in coronary artery disease patients.
- Therapeutic interventions, particularly revascularization, can improve prognosis in patients with silent ischemia.
Abstract:
The pathophysiology of silent ischemia remains unclear, but it is extremely prevalent in patients with coronary artery disease. Stress testing is the preferred method of detection, but Holter monitoring is reliable in recording ischemia during daily life and in evaluating therapy. Prognosis is adversely affected by silent ischemia, whether the patient is symptomatic or asymptomatic. A variety of pharmacologic agents can reduce the ischemic burden, and data suggest that such therapy improves prognosis, although not as much as coronary artery revascularization.
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina II: Classification
Angina IV: Management
Angina V: Nursing Management
Cardiomyopathy V: Interprofessional Care


